Meilleure Health Schedules 27 Aug 2026 Board Meeting to Review H1 Results and Dividend Proposal

Bulletin Express
Aug 13

Meilleure Health International Industry Group Limited will convene its board of directors on 27 August 2026 in Hong Kong. The session’s agenda includes:

• Examination and approval of the unaudited interim results for the six months ended 30 June 2026.

• Deliberation on a potential interim dividend for shareholders.

The announcement, dated 13 August 2026, confirms participation from the company’s full board—comprising three executive directors (Mr. Zhou Xuzhou, Dr. Zeng Wentao, Ms. Zhou Wen Chuan), one non-executive director (Dr. Mao Zhenhua) and three independent non-executive directors (Professor Chau Chi Wai, Wilton; Mr. Chen Shi; Mr. Wu Peng).

Executive Director and CEO Ms. Zhou Wen Chuan signed the notice on behalf of the board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10